Back to TMO
GLENVIEW CAPITAL MANAGEMENT, LLC → TMO
GLENVIEW CAPITAL MANAGEMENT, LLC TMO Position History
Thermo Fisher Scientific Inc. • Healthcare
Quarters held
5
Latest value
$314.5M
Q2 2026
Peak value
$314.5M
First seen
Q2 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q2 2025 | $40.5M |
| Q3 2025 | $137.2M |
| Q4 2025 | $129.8M |
| Q1 2026 | $123.1M |
| Q2 2026 | $314.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $314.5M | 627.2K | — | — |
| Q1 2026 | $123.1M | 250.5K | — | — |
| Q4 2025 | $129.8M | 223.9K | — | — |
| Q3 2025 | $137.2M | 282.9K | — | — |
| Q2 2025 | $40.5M | 100.0K | — | — |
Other funds holding TMO
$17.6B
$15.8B
$14.7B
$10.1B
$9.6B
$9.6B